| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/JAMA.1996.03540170048031 |
| P698 | PubMed publication ID | 8892715 |
| P50 | author | Jane A. Cauley | Q19668152 |
| Lewis Kuller | Q88077314 | ||
| P2093 | author name string | F L Lucas | |
| W S Browner | |||
| S R Cummings | |||
| M T Vogt | |||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bone fracture | Q68833 |
| breast cancer | Q128581 | ||
| osteoporosis | Q165328 | ||
| P304 | page(s) | 1404-1408 | |
| P577 | publication date | 1996-11-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group | |
| P478 | volume | 276 |
| Q35082355 | Anti-oestrogenic chemoprevention of breast cancer-the need to progress |
| Q34932305 | Anti-oestrogenic prevention of breast cancer--the make or break point |
| Q46406309 | Are breast density and bone mineral density independent risk factors for breast cancer? |
| Q36249907 | Assessing the economic impact of chronic conditions in postmenopausal women |
| Q36977873 | Association between Tumor Characteristics and Bone Mineral Density in Postmenopausal Breast Cancer Patients |
| Q41696431 | Association between bone mineral density and cognitive decline in older women |
| Q34936565 | Association between bone mineral density and incidence of breast cancer |
| Q33635581 | Associations between endogenous sex hormone levels and mammographic and bone densities in premenopausal women |
| Q46396329 | Axial BMD, change in BMD and bone turnover do not predict breast cancer incidence in early postmenopausal women |
| Q33708123 | Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk |
| Q36229440 | Bone loss and the aromatase inhibitors |
| Q55055663 | Bone loss associated with prevention of breast cancer. |
| Q44842659 | Bone mass density and risk of breast cancer and survival in older women |
| Q81251000 | Bone mass density, subsequent risk of colon cancer and survival in postmenopausal women |
| Q46049923 | Bone mineral density and breast cancer risk in postmenopausal women |
| Q42273295 | Bone mineral density and breast cancer risk: Results from the Vorarlberg Health Monitoring & Prevention Program and meta-analysis. |
| Q36803868 | Bone mineral density and mammographic density in Mexican women |
| Q43954762 | Bone mineral density and risk of breast cancer in postmenopausal women |
| Q24791506 | Bone mineral density and the subsequent risk of cancer in the NHANES I follow-up cohort |
| Q80973474 | Bone mineral density at menopause does not predict breast cancer incidence |
| Q43712545 | Bone mineral density is a prognostic factor for postmenopausal caucasian women with breast cancer |
| Q38787494 | Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis |
| Q35012885 | Bone versus breast density |
| Q45966605 | Breast cancer and bone mass in older women: is bone density prescreening for mammography useful? |
| Q77357663 | Breast cancer and hormone replacement therapy |
| Q39043528 | Cancer risk in patients with osteoporosis: a population-based cohort study |
| Q37509593 | Carcinoma In Situ Outcomes in National Surgical Adjuvant Breast and Bowel Project Breast Cancer Chemoprevention Trials |
| Q37561758 | Changes of The Uterine Tissue in Rats with Polycystic Ovary Syndrome Induced by Estradiol Valerate. |
| Q91628100 | Chemically induced carcinogenesis in rodent models of aging: assessing organismal resilience to genotoxic stressors in geroscience research |
| Q36169511 | Clinical management of osteoporosis in women with a history of breast carcinoma |
| Q37728394 | Combination of raloxifene, aspirin and estrogen as novel paradigm of hormone replacement therapy in rabbit model of menopause |
| Q36622882 | Components of metabolic syndrome and risk of breast cancer by prognostic features in the study of osteoporotic fractures cohort. |
| Q34191632 | Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation |
| Q45168977 | Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene |
| Q45196993 | Cost effectiveness of raloxifene in the treatment of osteoporosis in Sweden: an economic evaluation based on the MORE study |
| Q45239344 | Cost-effectiveness of raloxifene in the UK: an economic evaluation based on the MORE study |
| Q37355588 | Decreased risk of breast cancer associated with oral bisphosphonate therapy |
| Q41525346 | Dietary fat and chronic diseases: epidemiologic overview |
| Q50761373 | Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population. |
| Q61948775 | Effect of fenretinide on bone mineral density and metabolism in women with early breast cancer |
| Q41464715 | Elevated incidence of fractures in women with invasive breast cancer. |
| Q34638131 | Endogenous estrogens and breast cancer risk: the case for prospective cohort studies |
| Q74425483 | Epidemiology of osteoporosis in the United States of America |
| Q44630574 | Estrogen receptor alpha gene polymorphisms and endometrial cancer risk |
| Q37008462 | Exogenous and endogenous hormones and breast cancer |
| Q35165822 | Favorable cardiac risk among elderly breast carcinoma survivors |
| Q34999480 | Fracture in asian women with breast cancer occurs at younger age |
| Q33954508 | Fracture risk increases after diagnosis of breast or other cancers in postmenopausal women: results from the Women's Health Initiative. |
| Q33943644 | Future prospects for the prevention and cure of breast cancer |
| Q50020268 | HIF signaling in osteoblast-lineage cells promotes systemic breast cancer growth and metastasis in mice |
| Q34181916 | HRT and its impact on the menopause, osteoporosis and breast cancer |
| Q64994804 | High Bone Mineral Density of the Lumbar Spine Is Positively Associated with Breast Cancer. |
| Q34015747 | Hip bone density predicts breast cancer risk independently of Gail score: results from the Women's Health Initiative |
| Q35965644 | Hormonal and genetic risk factors for breast cancer. |
| Q34953339 | Hormonal risk factors for breast cancer: identification, chemoprevention, and other intervention strategies |
| Q33679258 | Identifying opportunities for cancer prevention during preadolescence and adolescence: puberty as a window of susceptibility |
| Q78023799 | Is there a reduced risk of breast cancer among women with hip fractures? |
| Q38886483 | Lifestyle factors affecting heel ultrasound in Greek females across different life stages |
| Q45981704 | Low bone mineral density at femoral neck is a predictor of increased mortality in elderly Japanese women. |
| Q35866345 | Low fatness, reduced fat intake and adequate plasmatic concentrations of LDL-cholesterol are associated with high bone mineral density in women: a cross-sectional study with control group |
| Q47403827 | Low risk of hip fracture among elderly breast cancer survivors |
| Q48287835 | Multimorbidity in women with and without osteoporosis: results from a large US retrospective cohort study 2004-2009. |
| Q31001228 | Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program |
| Q34049239 | Oral bisphosphonate use and breast cancer incidence in postmenopausal women |
| Q34104102 | Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort |
| Q44847641 | Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer. |
| Q74777731 | Osteoporosis: pathogenesis, diagnosis, and treatment in older adults |
| Q25257712 | Positive association between mammographic breast density and bone mineral density in the Postmenopausal Estrogen/Progestin Interventions Study |
| Q46901894 | Predicting risk of breast cancer in postmenopausal women by hormone receptor status |
| Q91641284 | Prevention of Osteoporosis in the Ovariectomized Rat by Oral Administration of a Nutraceutical Combination That Stimulates Nitric Oxide Production |
| Q64228188 | Relationship between bone mineral density and the risk of breast cancer: a systematic review and dose-response meta-analysis of ten cohort studies |
| Q34997308 | Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer |
| Q36478160 | Risk of Nongenitourinary Cancers in Patients With Spinal Cord Injury: A Population-based Cohort Study |
| Q34039811 | Risks and benefits of hormone replacement therapy |
| Q34638048 | Sex steroid hormones, bone mineral density, and risk of breast cancer |
| Q36709026 | Significant differences in UK and US female bone density reference ranges. |
| Q36633831 | Skeletal complications of breast cancer therapies |
| Q39033804 | Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy |
| Q56888461 | The Economics and Management of Osteoporosis in Postmenopausal Women |
| Q56888467 | The Pharmacoeconomics of Hormone Replacement Therapy |
| Q92109454 | The association between adherence with oral bisphosphonates and the risk of breast cancer in post-menopausal women |
| Q77220380 | The association between low bone mass at the menopause and cardiovascular mortality |
| Q37118480 | The association of bone mineral density with prostate cancer risk in the Osteoporotic Fractures in Men (MrOS) Study |
| Q37017268 | The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis |
| Q35150469 | The effects of adjuvant chemotherapy on bone density in postmenopausal women with early breast cancer |
| Q73363823 | The relation between stress fractures and bone mineral density: evidence from active-duty Army women |
| Q80602449 | The relationship between breast density and bone mineral density in postmenopausal women |
| Q46576596 | Therapeutic potential of oestrogen receptor ligands in development for osteoporosis |
| Q36393138 | Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy |
| Q34108855 | Update on the epidemiology of osteoporosis. |
Search more.